Quality assessment of global clinical practice guidelines for transplantation in 2017_Chinese Journal of Evidence-Based Medicine

Authors：

 ZHU Zhijun ^1,2 , SUN Liying ^1,2 , ZHANG Haiming ^1,2 , SHI Yuexian ³

1. Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R.China;
2. National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, P.R.China;
3. School of Nursing, Peking University, Beijing, 100191, P.R.China;

Corresponding?author：

ZHU Zhijun, Email: zhu-zhijun@outlook.com

Keywords：

Transplantation; Clinical practice guideline; Quality assessment; AGREE Ⅱ

DOI：

10.7507/1672-2531.201805093

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

ObjectivesTo assess the quality of clinical practice guidelines for transplantation in 2017. MethodsPubMed, NICE, NGC, NCCN, SIGN, CMA Infobase and GIN databases were searched online to collect guidelines for transplantation published in 2017. Guidelines were then assessed by using the AGREE Ⅱ instrument. ResultsA total of 10 guidelines were included. The result of assessments by the AGREE Ⅱ instrument showed a clear discrepancy among domains (P=0.001). Satisfactory scores were found in domains of " scope and purpose”, " clarity of presentation” and " overall score”, where the average scores were 90.8% (95%CI 83.5% to 98.1%), 82.5% (95%CI 72.7% to 92.3%) and 75.6% (95%CI 66.6% to 84.6%), respectively. Low scores were found in domains of " stakeholder involvement” and " applicability”, in which a score of 40.0% (95%CI 32.4% to 47.6%) and a score of 27.8% (95%CI 11.2% to 44.5%) were achieved, respectively. ConclusionsThere is a clear discrepancy among domains of global clinical practice guidelines for transplantation in 2017. Guidelines in this field should be improved in " stakeholder involvement” and " applicability”.

Citation： ZHU Zhijun, SUN Liying, ZHANG Haiming, SHI Yuexian. Quality assessment of global clinical practice guidelines for transplantation in 2017. Chinese Journal of Evidence-Based Medicine, 2018, 18(9): 964-968. doi: 10.7507/1672-2531.201805093 Copy

1.	朱志軍, 曾志貴. 兒童肝移植術后早期血管并發癥的診斷、治療及預防. 中國普外基礎與臨床雜志, 2015, 22(12): 1425-1427.
2.	曲偉, 孫麗瑩, 朱志軍, 等. CD4+T 細胞-iATP 在監測肝臟移植術后感染性疾病的有效性. 中華實驗外科雜志, 2015, 32(10): 2419.
3.	孫麗瑩, 朱志軍, 魏林, 等. 肝移植治療兒童遺傳代謝性疾病 42 例. 中華器官移植雜志, 2017, 38(6): 337-342.
4.	朱志軍. 小肝綜合征的防治策略與進展. 中國普外基礎與臨床雜志, 2017, 24(8): 923-926.
5.	陳虹, 張慶, 張文學, 等. 肝移植術后中遠期肺部真菌感染. 中華醫院感染學雜志, 2009, 19(16): 2096-2098.
6.	陳虹, 王旭, 張慶, 等. 肝移植術后中遠期黃疸的原因分析與治療. 中華器官移植雜志, 2012, 33(2): 97-100.
7.	霍楓. 公民心臟死亡器官捐獻開啟我國器官移植新時代. 器官移植, 2013, 4(5): 247-249.
8.	姜賢飛, 朱方, 劉琴, 等. 我國器官移植立法存在的問題與思考. 中國循證醫學雜志, 2010, 10(11): 1353-1355.
9.	曹林平, 吳健. 肝癌肝移植受體的選擇標準. 中華肝臟病雜志, 2018, 26(2): 84-87.
10.	Mitka M. Groups aim for trustworthy clinical practice guidelines. JAMA, 2014, 311(12): 1187-1188.
11.	Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
12.	Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant, 2017, 23(9): 1422-1428.
13.	Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol, 2017, 35(18): 2082-2094.
14.	Miller CM, Quintini C, Dhawan A, et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplantation, 2017, 101(5): 938-944.
15.	Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. Available at: https://www.nice.org.uk/guidance/ipg602/chapter/1-Recommendations.
16.	Immunosuppressive therapy for kidney transplant in adults. Available at: https://www.nice.org.uk/guidance/ta481.
17.	Immunosuppressive therapy for kidney transplant in children and young people. Available at: https://www.nice.org.uk/guidance/ta482.
18.	Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American society for blood and marrow transplantation. Biol Blood Marrow Transplant, 2017, 23(11): 1826-1838.
19.	Sung L, Robinson P, Treister N, et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support Palliat Care, 2017, 7(1): 7-16.
20.	Silla L, Dulley F, Saboya R, et al. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia. Eur J Haematol, 2017, 98(2): 177-183.
21.	Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect, 2018, 51(3): 287-301.
22.	江梅, 廖理粵, 羅煒, 等. 國內咳嗽診療指南的質量評價. 中國循證醫學雜志, 2015, 15(4): 409-413.
23.	Choi TY, Choi J, Lee JA, et al. The quality of clinical practice guidelines in traditional medicine in Korea: appraisal using the AGREE II instrument. Implement Sci, 2015, 10: 104.
24.	李楠, 姚亮, 吳瓊芳, 等. 2012~2013 年中國大陸期刊發表臨床實踐指南質量評價. 中國循證醫學雜志, 2015, 15(3): 259-263.

1. 朱志軍, 曾志貴. 兒童肝移植術后早期血管并發癥的診斷、治療及預防. 中國普外基礎與臨床雜志, 2015, 22(12): 1425-1427.
2. 曲偉, 孫麗瑩, 朱志軍, 等. CD4+T 細胞-iATP 在監測肝臟移植術后感染性疾病的有效性. 中華實驗外科雜志, 2015, 32(10): 2419.
3. 孫麗瑩, 朱志軍, 魏林, 等. 肝移植治療兒童遺傳代謝性疾病 42 例. 中華器官移植雜志, 2017, 38(6): 337-342.
4. 朱志軍. 小肝綜合征的防治策略與進展. 中國普外基礎與臨床雜志, 2017, 24(8): 923-926.
5. 陳虹, 張慶, 張文學, 等. 肝移植術后中遠期肺部真菌感染. 中華醫院感染學雜志, 2009, 19(16): 2096-2098.
6. 陳虹, 王旭, 張慶, 等. 肝移植術后中遠期黃疸的原因分析與治療. 中華器官移植雜志, 2012, 33(2): 97-100.
7. 霍楓. 公民心臟死亡器官捐獻開啟我國器官移植新時代. 器官移植, 2013, 4(5): 247-249.
8. 姜賢飛, 朱方, 劉琴, 等. 我國器官移植立法存在的問題與思考. 中國循證醫學雜志, 2010, 10(11): 1353-1355.
9. 曹林平, 吳健. 肝癌肝移植受體的選擇標準. 中華肝臟病雜志, 2018, 26(2): 84-87.
10. Mitka M. Groups aim for trustworthy clinical practice guidelines. JAMA, 2014, 311(12): 1187-1188.
11. Appraisal of guidelines for research & evaluation Ⅱ instrument. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-Ⅱ-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
12. Dietz AC, Savage SA, Vlachos A, et al. Late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes: consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant, 2017, 23(9): 1422-1428.
13. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol, 2017, 35(18): 2082-2094.
14. Miller CM, Quintini C, Dhawan A, et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplantation, 2017, 101(5): 938-944.
15. Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure. Available at: https://www.nice.org.uk/guidance/ipg602/chapter/1-Recommendations.
16. Immunosuppressive therapy for kidney transplant in adults. Available at: https://www.nice.org.uk/guidance/ta481.
17. Immunosuppressive therapy for kidney transplant in children and young people. Available at: https://www.nice.org.uk/guidance/ta482.
18. Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American society for blood and marrow transplantation. Biol Blood Marrow Transplant, 2017, 23(11): 1826-1838.
19. Sung L, Robinson P, Treister N, et al. Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Support Palliat Care, 2017, 7(1): 7-16.
20. Silla L, Dulley F, Saboya R, et al. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia. Eur J Haematol, 2017, 98(2): 177-183.
21. Ko BS, Chen WT, Kung HC, et al. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect, 2018, 51(3): 287-301.
22. 江梅, 廖理粵, 羅煒, 等. 國內咳嗽診療指南的質量評價. 中國循證醫學雜志, 2015, 15(4): 409-413.
23. Choi TY, Choi J, Lee JA, et al. The quality of clinical practice guidelines in traditional medicine in Korea: appraisal using the AGREE II instrument. Implement Sci, 2015, 10: 104.
24. 李楠, 姚亮, 吳瓊芳, 等. 2012~2013 年中國大陸期刊發表臨床實踐指南質量評價. 中國循證醫學雜志, 2015, 15(3): 259-263.

Previous Article
Efficacy of Chinese herbal medicine combined with chemotherapy for ovarian cancer: a systematic review
Next Article
The importance of dissemination of evidence-based medicine to right care

Chinese Journal of Evidence-Based Medicine

Quality assessment of global clinical practice guidelines for transplantation in 2017

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content